NCT04909411View on ClinicalTrials.gov

Consequences of a Maternal-fetal Chikungunya Virus Infection

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

October 12, 2021

Study Completion Date

October 12, 2021

Conditions
Chikungunya Virus Infection
Interventions
OTHER

OPHTHALMOLOGICAL ASSESSMENT

assessment of eye mobility (search for heterophoria or strabismus), visual acuity, visual fields, external structures and funduscopic examination

OTHER

NEUROPSYCHOLOGICAL ASSESSMENT

completion of WISC-5, Vineland Adaptive Behavior Scale II and Strengths and Difficulties Questionnaire

Trial Locations (1)

97410

CHU de La Réunion, Saint-Pierre

All Listed Sponsors
lead

Centre Hospitalier Universitaire de la Réunion

OTHER

NCT04909411 - Consequences of a Maternal-fetal Chikungunya Virus Infection | Biotech Hunter | Biotech Hunter